HSV+ means a person has tested positive for herpes simplex virus, either type 1 (HSV-1) or type 2 (HSV-2). It’s one of the most common viral infections in the world: roughly 64% of people under 50 have HSV-1, and about 13% of people aged 15 to 49 have HSV-2, according to World Health Organization estimates from 2020. If you’ve just received a positive result or seen this term on someone’s dating profile, here’s what it actually means for your body and your daily life.
HSV-1 vs. HSV-2
There are two types of herpes simplex virus, and they behave differently depending on where they establish themselves. HSV-1 is the main cause of oral herpes, the virus behind cold sores on or around the mouth. Most people pick it up during childhood through non-sexual contact like a kiss from a family member. HSV-2 is the primary cause of genital herpes and is almost always transmitted through sexual contact.
That said, the lines aren’t absolute. HSV-1 can cause genital herpes through oral sex, and this has become increasingly common. Both types create a lifelong infection because the virus retreats into nerve cells and stays dormant between outbreaks. Being HSV+ for either type means the virus is present in your body permanently, though many people rarely or never experience symptoms.
What an HSV+ Test Result Means
Most HSV testing relies on blood tests that detect antibodies your immune system produces in response to the virus. The two antibody types that matter are IgM and IgG, and they tell different stories.
IgM antibodies show up within 3 to 4 days of an initial infection and fade after a few weeks. They sound useful for catching a new infection early, but they’re unreliable in practice. IgM tests can’t distinguish between HSV-1 and HSV-2, they sometimes react to other viruses in the herpes family, and they can pop up during a recurrent outbreak rather than just a first infection. Most experts don’t recommend relying on IgM results alone.
IgG antibodies take at least two weeks to develop but persist for years. A type-specific IgG test can differentiate between HSV-1 and HSV-2, which is why it’s the preferred blood test. If your results say “HSV-2 IgG positive,” it means your immune system has produced lasting antibodies against HSV-2 specifically.
When Results Fall in a Gray Zone
IgG tests report a numerical index value, not just a positive or negative. Per CDC guidelines, initial HSV-2 IgG results with index values between 1.1 and 3.0 carry a higher risk of being false positives and should be confirmed with a second, different test method. False positives are more common with herpes blood tests than with tests for infections like chlamydia or gonorrhea. If your result falls in that low-positive range, a confirmatory test can clarify whether the initial result was accurate.
Why Routine Screening Isn’t Standard
You might be surprised to learn that the CDC does not recommend herpes blood testing for people without symptoms in most situations. The reason comes down to test accuracy: the chance of a false positive is high enough that screening large numbers of low-risk, symptom-free people would generate a significant number of incorrect results, causing unnecessary anxiety.
Testing is recommended when you have genital symptoms that could be herpes, when a healthcare provider sees signs of herpes during an exam, or when you have or have had a sexual partner with genital herpes. If you have an active sore or blister, a direct swab of the lesion is the most reliable way to confirm HSV and identify which type is involved.
Symptoms and Outbreaks
Many people who are HSV+ never realize it. The virus can live in the body without causing noticeable symptoms, a state called asymptomatic shedding, where the virus is present on the skin or mucous membranes without producing visible sores. When symptoms do occur, they typically appear as clusters of small, painful blisters that break open, form shallow ulcers, and crust over within one to two weeks.
A first outbreak tends to be the most severe. You might experience flu-like symptoms alongside the sores, including fever, body aches, and swollen lymph nodes. Recurrent outbreaks are usually milder and shorter. Over time, most people experience fewer outbreaks per year as the immune system learns to keep the virus in check. Some people have one or two episodes and never have another; others deal with several recurrences annually, especially in the first year or two.
Common triggers for recurrent outbreaks include illness, stress, fatigue, sun exposure, and hormonal changes like menstruation. Recognizing your personal triggers can help you anticipate and manage flare-ups.
Reducing Transmission Risk
HSV spreads through direct skin-to-skin contact with an infected area, whether or not sores are visible. The virus can shed asymptomatically, which is why transmission sometimes happens when a person has no symptoms at all. Two strategies significantly lower the risk of passing the virus to a partner.
Consistent condom use reduces HSV-2 transmission risk by about 30%, based on a pooled analysis of clinical data. That number reflects 100% consistent use during vaginal or anal sex. Every additional 25% of the time condoms are used reduces risk by roughly 7%. Condoms don’t cover all potentially affected skin, which is why the protection isn’t higher, but they still make a meaningful difference.
Daily suppressive antiviral therapy is the other major tool. Taking antiviral medication every day reduces both the frequency of outbreaks and the amount of viral shedding between outbreaks. The combination of daily antivirals and consistent condom use provides the greatest risk reduction. Avoiding sexual contact during active outbreaks, when viral shedding is at its highest, is also important.
Living With HSV+ Status
Daily antiviral therapy is an option for anyone who wants fewer outbreaks or wants to lower the chance of transmitting the virus to a partner. For people with frequent recurrences (roughly 10 or more episodes per year), higher doses may be more effective than lower ones. Your prescriber can help determine the right approach based on how often outbreaks happen and your goals for treatment.
For people who have infrequent outbreaks, episodic treatment is another option. This means keeping antiviral medication on hand and starting it at the first sign of an outbreak, such as tingling, itching, or redness in the area where sores typically appear. Starting treatment early can shorten the outbreak and reduce its severity.
HSV and Pregnancy
The biggest concern with herpes during pregnancy is the risk of passing the virus to the baby during delivery, particularly through contact with active lesions in the birth canal. Neonatal herpes is rare but serious. To reduce this risk, pregnant individuals with a history of genital herpes are commonly started on antiviral medication at 36 weeks of gestation and continue through delivery. This lowers the chance of an active outbreak at the time of birth.
If active genital lesions are present when labor begins, a cesarean delivery is typically recommended. This significantly reduces, though does not completely eliminate, the risk of neonatal infection. The highest risk scenario is a new genital herpes infection acquired late in pregnancy, because the body hasn’t yet built up antibodies that help protect the baby.
The Emotional Side
For many people, the hardest part of being HSV+ isn’t the physical symptoms. It’s the stigma. The reality is that herpes is extraordinarily common, and the vast majority of people carrying the virus live normal, healthy lives with minimal disruption. An HSV-1 positive result, in particular, reflects the same virus that causes cold sores in roughly two-thirds of the global population under 50.
Disclosure to sexual partners can feel daunting, but it gets easier with practice and accurate information. Knowing your type, understanding your options for reducing transmission, and being able to speak plainly about risk gives both you and your partner the tools to make informed decisions together.